Phenylketonurias - 25 Studies Found
| Active, not recruiting |
: Kuvan® in Phenylketonuria Patients Less Than 4 Years Old : Phenylketonuria : 2011-06-17 :
|
| Completed |
: The Effect of Supplemental Docosahexaenoic Acid (DHA) on Neurocognitive Outcomes in Teen and Adult Women With Phenylketonuria(PKU) : Phenylketonuria : 2009-05-01 :
|
| Completed |
: Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients : Phenylketonuria : 2010-04-27 :
|
| Completed |
: Low Phenylalanine Diet for Mothers With Phenylketonuria (PKU) : Phenylketonuria : 2003-07-21 : Behavioral: Restricted phenylalanine diet |
| Completed |
: Response to Kuvan® in Subjects With Phenylketonuria (PKU) in a 4 Weeks Testing Period : Phenylketonuria : 2010-03-05 : Drug: Kuvan® Kuvan® (sapropterin dihydrochloride) oral solution 20 milligram per kilogram (mg/ |
| Completed |
: Kuvan Therapy in Phenylketonuria (PKU): The Effect of Blood Phenylalanine Concentration on Kuvan Response : Phenylketonuria : 2009-02-10 : Drug: Kuvan 20mg/kg/d, once daily Other Name: saprop |
| Completed |
: The Effects of Kuvan on Functional Brain Connectivity in Individuals With Phenylketonuria (PKU) : Phenylketonuria : 2009-08-21 : Drug: Sapropterin Sapropterin (Kuvan) 20mg/kg/day taken once daily or as otherwise prescribed by physici |
| Completed |
: Safety and Tolerability Study of rAvPAL-PEG to Treat Phenylketonuria : Phenylketonuria : 2008-03-06 : Drug: rAvPAL-PEG rAvPAL-PEG will be administered as a single, SC injection at dose levels of 0.001, 0.00 |
| Completed |
: Study to Evaluate the Effects of Kuvan on Individuals With Phenylketonuria (PKU) With Maladaptive Behaviors : Phenylketonuria : 2008-07-30 |
| Completed |
: Fluorodeoxyglucose Positron Emission Tomography (FDG PET) Findings in Patients With Phenylketonuria Before and After KUVAN Therapy : Phenylketonuria : 2009-09-28 : Drug: Sapropterin All subjects will receive 20 mg/kg/day Sapropterin (KUVAN) for four months. Subjects w |